Advertisement
Advertisement
SVA
Sinovac Biotech, Ltd
6.47
USD0.00
0.00%
Mar 28, 09:30 UTC -4
Closed
After-Market
6.47
0.00
0.00%
Sinovac Biotech, Ltd Profile
About
Info & Links
CEO
Weidong Yin
Headquarters
BEIJING, F4 100085, CHINA
Industry
Sector
Website
Auditor
Marcum Bernstein & Pinchuk LLP
Share holders
--
Employees
5,505
Sinovac Biotech, Ltd Statistics
Valuation Measures
Market Capitalization2
464.94M
Enterprise Value
-300.52M
Enterprise Value/EBITDA(ttm)
-1.38
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
0.06
Price to Cash(ytd)
38.95
Profitability
Gross Margin(ttm)
65.40%
Operating Margin(ttm)
--
Profit Margin(ttm)
-1.67%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
18.42%
Return on Assets(ttm)
--
Income Statement
Revenue(ttm)
458.30M
Revenue Per Share(ttm)
--
Gross Profit(ttm)
398.68M
EBITDA(ttm)3
218.09M
Net Income Available to Common(ttm)
109.61M
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
0.01
52-Week Change
--
S&P 500 52-Week Change
5.43%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
--
Dividend Yield
0.00%
Float4
86.89M
% Held by Insiders
12.79%
% Held by Institutions
0.00%
Balance Sheet
Total Cash(mrq)
10.58B
Total Cash Per Share(mrq)
--
Total Debt(mrq)
309.67M
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
--
Quick Ratio(mrq)
11.24%
Book Value Per Share(mrq)
--
Cash Flow
Operating Cash Flow Per Share(ytd)
--
Free Cash Flow(ytd)
0.00
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement